Brief: Day One Announces Cooperative Research And Development Agreement With National Cancer Institute

Day One Biopharmaceuticals

17/10/2022 13:40

Oct 17 (Reuters) - Day One Biopharmaceuticals Inc
 DAWN.O :
    * DAY ONE ANNOUNCES COOPERATIVE RESEARCH AND DEVELOPMENT
AGREEMENT
WITH NATIONAL CANCER INSTITUTE TO EXPAND DEVELOPMENT OF
TOVORAFENIB (DAY101)

Source text for Eikon:  ID:nGNX4NXrzH 
Further company coverage:  DAWN.O 
 ((Reuters.Briefs@thomsonreuters.com;))